David Nutt reveals why cannabis may not induce the same brain state as psilocybin for therapy.
In this 'Ask David Anything' episode, Professor David Nutt engages with community members Andrew, Raj, and Neve on topics including using cannabis as a psychedelic therapy, comparing it to ketamine, and discussing regulatory hurdles for MDMA and psilocybin. The conversation explores innovative approaches like vaping for dose titration, the importance of peak experiences, and strategies to advance psychedelic medicine in the UK and globally.
